FDA Approves RVMD's RASONQUE for Pancreatic Cancer as Sellas' SLS009 Remains Preclinical
The U.S. Food and Drug Administration approved Revolution Medicines' RASONQUE on Wednesday for adults with metastatic pancreatic cancer who have tried chemotherapy or cannot take multi-drug regimens. The approval drew attention to Sellas Life Sciences' experimental drug SLS009, which is in
GateMacroTradfiHub·08-27 04:14
